Published in Transpl Int on December 01, 1989
A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35
The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat (1992) 6.51
The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol (1999) 6.19
Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol (2004) 3.80
Confirmation of a prognostic index in primary breast cancer. Br J Cancer (1987) 3.29
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg (1989) 2.84
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology (1992) 2.75
Relationship of oestrogen-receptor status to survival in breast cancer. Lancet (1979) 2.55
Relationship between primary breast tumor receptor status and patient survival. Cancer (1980) 2.49
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Can preliminary screening of dyspeptic patients allow more effective use of investigational techniques? Br Med J (Clin Res Ed) (1985) 2.37
Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology (2002) 2.35
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol (2001) 2.21
Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab (1988) 2.20
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol (1995) 2.20
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer (2001) 2.16
Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant (1992) 2.03
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer (2004) 1.97
Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer (1989) 1.97
Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res (1978) 1.95
Prognostic factors in upper G.I. bleeding. Endoscopy (1986) 1.94
Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology (1995) 1.90
Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. Br J Cancer (1978) 1.90
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol (2000) 1.88
Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res (1990) 1.85
The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol (2000) 1.82
Screening interval breast cancers: mammographic features and prognosis factors. Radiology (1996) 1.82
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology (1994) 1.78
Prognostic factors in breast cancer -- the formation of a prognostic index. Clin Oncol (1979) 1.74
A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization. Histopathology (1984) 1.72
Cytological grading of breast carcinoma--a feasible proposition? Cytopathology (1990) 1.70
Divergent views of hospital staff on detecting and managing hypertension. Br Med J (1979) 1.65
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin Cancer Res (1999) 1.65
Single nucleotide polymorphism markers for genetic mapping in Drosophila melanogaster. Genome Res (2001) 1.63
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer (1995) 1.60
Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer (2000) 1.58
Transfer of computer-aided diagnosis of dyspepsia from one geographical area to another. Gut (1976) 1.57
Early-onset breast cancer--histopathological and prognostic considerations. Br J Cancer (1997) 1.56
Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol (1987) 1.54
Season of initial detection in breast cancer. Br J Cancer (1991) 1.52
The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. Gut (1990) 1.49
The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant (1999) 1.49
Ascending polyneuropathy in leptospirosis--a case study. Ann Trop Med Parasitol (1980) 1.47
C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Br J Cancer (1996) 1.44
Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol (Oxf) (1973) 1.44
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Subcutaneous mastectomy for primary operable breast cancer. Br J Surg (1984) 1.43
The role of the radiologist in breast diagnosis: a surgeon's personal view. Clin Radiol (1998) 1.43
The prediction of local or regional recurrence after simple mastectomy for operable breast cancer. Br J Surg (1985) 1.42
Cyclosporin toxicity and colitis. Lancet (1988) 1.42
Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival. J R Coll Surg Edinb (1990) 1.41
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br J Cancer (1995) 1.40
Cardiac tamponade from central venous catheters. Report of a case and review of the English literature. Angiology (1984) 1.39
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol (1995) 1.39
Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer (1981) 1.38
Paget's disease of the nipple. Br J Surg (1991) 1.38
c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer (1991) 1.37
Clinical findings, early endoscopy, and multivariate analysis in patients bleeding from the upper gastrointestinal tract. Br Med J (1977) 1.35
Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur J Surg Oncol (1995) 1.34
A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. Br J Cancer (1991) 1.32
Steroid receptors in early breast cancer: value in prognosis. J Steroid Biochem (1981) 1.31
Results from a seven-year programme of breast self-examination in 89,010 women. Br J Cancer (1989) 1.31
Immunocytochemical localization of estrogen receptor in human breast tissue. Cancer Res (1988) 1.31
Macrophage clearance function and immune complex disease in New Zealand Black/White F1 hybrid mice. Clin Exp Immunol (1976) 1.30
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene (1998) 1.30
Renal function in patients over 40 with homozygous sickle-cell disease. Br Med J (Clin Res Ed) (1981) 1.30
PCBs and dioxin-like compounds in plasma of adult Inuit living in Nunavik (Arctic Quebec). Chemosphere (1997) 1.30
Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. BMJ (1988) 1.29
Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy. Lancet (1981) 1.29
Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator. Br Med J (Clin Res Ed) (1985) 1.29
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast Cancer Res Treat (1994) 1.27
Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. Aust N Z J Surg (1996) 1.26
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Clin Cancer Res (2000) 1.26
Preoperative diagnosis in carcinoma of the breast. Br J Surg (1977) 1.26
c-erbB-4 protein expression in human breast cancer. Br J Cancer (2000) 1.25
Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol (1990) 1.25
Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer (1994) 1.25
Relationship between macrophage clearance of PVP and affinity of anti-protein antibody response in inbred mouse strains. Nature (1975) 1.24
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. Br J Cancer (1986) 1.24
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer (1987) 1.23
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer (2005) 1.23
Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma. Br J Cancer (1987) 1.23
A comparison of the use of the "Tru-Cut" needle and fine needle aspiration cytology in the pre-operative diagnosis of carcinoma of the breast. Histopathology (1978) 1.22
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol (1986) 1.22
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer (1993) 1.22
Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int (1991) 1.22
Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer (2007) 1.20
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol (1999) 1.20
p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. Br J Cancer (1992) 1.19
Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant (1991) 1.18
Objective measurement of therapeutic response in breast cancer using tumour markers. Br J Cancer (1991) 1.18
Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology (1995) 1.17
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery (1988) 1.17
Calcium excretion (CaE) in metastatic breast cancer. Br J Surg (1983) 1.16
Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol (1999) 1.16